3,4-Dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
申请人:Adams L. Jerry
公开号:US20050075352A1
公开(公告)日:2005-04-07
Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
小说替代喹唑啉化合物和组合物,用于治疗作为CSBP/p38激酶抑制剂。
3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
申请人:SmithKline Beecham Corporation
公开号:EP1248624A1
公开(公告)日:2002-10-16
EP1248624A4
申请人:——
公开号:EP1248624A4
公开(公告)日:2003-01-22
US6759410B1
申请人:——
公开号:US6759410B1
公开(公告)日:2004-07-06
[EN] 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS<br/>[FR] 3,4-DIHYDRO-(1H)-QUINAZOLEIN-2-ONES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA KINASE CSBP/P38
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2001037837A1
公开(公告)日:2001-05-31
Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.